Specifically in breast cancer, increased ERK5 protein levels are associated with decreased disease-free survival and furthermore, MEK5 expression is up-regulated by constitutive activation of STAT (signal transducer and activator of transcription) 3, commonly detected in advanced breast cancer [15, 16]. Here, MAP2K5 is linked to breast carcinoma.